Metabolic Disorders Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
Metabolism is a process through which food is broken-down into sugars and acids in the body. Metabolic disorders disturb and lead to excess or scarcity of essential substances that help individuals to stay healthy. These disorders are either inherited or acquired during the lifetime of a person. Phenylketonuria is an example of inherited metabolic disorder, in which the body is unable to breakdown the amino acid phenylalanine. Other prominent metabolic disorders include type 1 diabetes, Gaucher’s disease, maple syrup urine disease, cystinosis, Fabry disease, Hartnup disease, Hunter syndrome, Hurler syndrome, Von Gierke disease, and hereditary hemochromatosis. Metabolic disorders are treated by normalizing the metabolic balance by reversing the cause of the disorder and administering medication to continue the proper metabolic function.
Multimodal treatment is used to treat metabolic disorders that include mineral supplements, vitamin supplements, bone marrow supplements, physical therapy, specific surgical interventions, and medications for reducing the symptoms of metabolic disorders.
The global metabolic disorders market is expected to grow substantially due to introduction of patient support programs for the treatment of various metabolic disorders. The key players in the market are providing co-pay assistance to patients who need medications for diabetes, obesity, hypercholesterolemia, and lysosomal storage disease. Moreover, many organizations such as the National Gaucher Foundation, the National Organization for Rare Disorders, and the National Gaucher Foundation of Canada, are involved in providing financial support to patients to continue with the therapy for metabolic diseases. Assistance programs by drug suppliers, encourage patients to buy branded therapeutics, which is expected to contribute to the growth of the market over the coming years.
The metabolic disorders market is segmented based on types of diseases and region. In terms of types of diseases, the market can be segmented into diabetes, obesity, hypercholesterolemia, and lysosomal storage diseases. The diabetes segment, is expected to register high growth during the forecast period. Increasing prevalence of diabetes and a huge patient base are factors propelling the growth of this segment. According to the International Diabetes Federation, in 2016, nearly 422 million people worldwide were living with diabetes. It is predicted that by 2040 more than 10% of the world’s adult population, which is around 642 million people will have diabetes.
Geographically, the global metabolic disorders market is segmented into North America, Europe, Asia Pacific and the rest of the world (RoW). North America is expected to dominate the market during the forecast period due to the availability of advanced technologies and higher penetration of diabetes care services across the region. The U.S. was a major regional contributor, owing to the high prevalence of diabetes in the geriatric population. According to the American Diabetes Association, over 25% of the diabetic patients in the U.S. are aged 65 years and above. Following North America, Asia Pacific is expected to be the most prominent market for metabolic disorder over the forecast period. Healthcare reforms across the region and rising diabetic population especially in India is anticipated to boost the growth in the Asia Pacific market.
The key players operating in the metabolic disorders market include Novo Nordisk A/S, Sanofi, Merck, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline plc, Pfizer, Inc., Biocon, and F. Hoffmann-La Roche. Companies engage in strategic collaborations, partnerships agreements, and develop new product and services to gain a competitive edge in the market.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017